HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Campaign for Safe Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder should remove phthalates - chemicals linked to cancer and reproductive disorders - from all of its products in every market, consumer advocacy organization states in a Feb. 7 release. CFSC points to Winter 2007 Consumer Reports which identified Lauder's Aveda Love Pure-Fume Essence, Clinique Happy and Estee Lauder Beautiful as containing phthalates DEP and DEHP, though the ingredients were not listed on the packaging. While DEHP is banned from cosmetics in Europe, both the European and U.S. samples of Happy and Beautiful were found to contain the chemical. The organization is behind a pledge to cleanse cosmetics of all ingredients banned overseas for associated health risks. More than 500 companies have signed on; Estee Lauder is not one of them (1"The Rose Sheet" Feb. 5, 2007, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel